Drug Target Review2025-11-13T08:30:27
Shift Bioscience have announced new research revealing that AI-driven virtual cell models perform far better than previously thought when assessed with correctly calibrated metrics.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-07-31T06:00:00Z
Contributor Dr Davinder Ramsingh, Drug Target Review
2026-07-01T13:30:00
Contributor Carrie Maynard and Dr Veronica Fowler
2026-06-09T08:20:00
Contributor Steve Smith, Drug Target Review
2025-05-08T09:00:00
Contributor Ning Ren
2024-01-24T12:52:38
Sponsored by BellBrook Labs
2023-02-16T14:53:10
Sponsored by Cell Signaling Technology
Site powered by Webvision Cloud